Skip to main content
Top
Published in: Endocrine 3/2014

01-12-2014 | Original Article

Plasma growth arrest-specific protein 6 levels in premenopausal and postmenopausal women: the role of endogenous estrogen

Authors: Yi-Jen Hung, Chien-Hsing Lee, Yi-Shing Shieh, Fone-Ching Hsiao, Fu-Huang Lin, Chang-Hsun Hsieh

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Growth arrest-specific 6 (Gas6) is a vitamin K-dependent protein that interacts with receptor tyrosine kinases of the Tyro-3, AXL, Mer (TAM) family. The Gas6/TAM system contributes to the regulation of cell survival and proliferation, cell adhesion and migration, and inflammatory cytokines release. Plasma Gas6 plays an important role in the inflammatory process, and is involved in diverse human diseases. Few studies have investigated gender-specific variations in plasma Gas6 concentration. Hence, the aim of this study was to determine whether plasma Gas6 levels are associated with sex hormones in premenopausal and postmenopausal women. A total of 103 premenopausal and 135 postmenopausal women were recruited. Plasma Gas6 concentration, estradiol (E2), and sex hormone-binding globulin were assayed. The free estrogen index (FEI) was calculated. The results showed significantly lower Gas6 levels in the postmenopausal compared to the premenopausal women (P < 0.005). Plasma Gas6 levels were positively correlated with E2 levels in the pre- and postmenopausal women (r = 0.359, P < 0.001 and r = 0.261, P = 0.002, respectively). Gas6 levels were also correlated with FEI in the pre- and postmenopausal women (r = 0.234, P = 0.017 and r = 0.188, P = 0.029, respectively). After adjusting for confounders, the correlations still remained significant. In multiple stepwise regression analysis, only E2 in premenopausal and both age and E2 in postmenopausal women were independently correlated with the plasma Gas6 levels (all P < 0.001). These results suggest that plasma Gas6 is associated with sex hormones in both pre- and postmenopausal women, indicating a potential role of sex hormones in the Gas6/TAM system.
Literature
1.
go back to reference G. Manfioletti, C. Brancolini, G. Avanzi, C. Schneider, The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol. 13, 4976–4985 (1993)PubMedCentralPubMed G. Manfioletti, C. Brancolini, G. Avanzi, C. Schneider, The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol. 13, 4976–4985 (1993)PubMedCentralPubMed
2.
go back to reference C. Ekman, J. Stenhoff, B. Dahlback, Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J. Thromb. Haemost. 8, 838–844 (2010)PubMedCrossRef C. Ekman, J. Stenhoff, B. Dahlback, Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J. Thromb. Haemost. 8, 838–844 (2010)PubMedCrossRef
3.
go back to reference I. Balogh, S. Hafizi, J. Stenhoff, K. Hansson, B. Dahlback, Analysis of Gas6 in human platelets and plasma. Arterioscler. Thromb. Vasc. Biol. 25, 1280–1286 (2005)PubMedCrossRef I. Balogh, S. Hafizi, J. Stenhoff, K. Hansson, B. Dahlback, Analysis of Gas6 in human platelets and plasma. Arterioscler. Thromb. Vasc. Biol. 25, 1280–1286 (2005)PubMedCrossRef
4.
go back to reference M. Yanagita, Y. Ishimoto, H. Arai, K. Nagai, T. Ito, T. Nakano, D.J. Salant, A. Fukatsu, T. Doi, T. Kita, Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Investig. 110, 239–246 (2002)PubMedCentralPubMedCrossRef M. Yanagita, Y. Ishimoto, H. Arai, K. Nagai, T. Ito, T. Nakano, D.J. Salant, A. Fukatsu, T. Doi, T. Kita, Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Investig. 110, 239–246 (2002)PubMedCentralPubMedCrossRef
5.
go back to reference E. Lutgens, M. Tjwa, P. Garcia de Frutos, E. Wijnands, L. Beckers, B. Dahlback, M.J. Daemen, P. Carmeliet, L. Moons, Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J. Pathol. 216, 55–63 (2008)PubMedCrossRef E. Lutgens, M. Tjwa, P. Garcia de Frutos, E. Wijnands, L. Beckers, B. Dahlback, M.J. Daemen, P. Carmeliet, L. Moons, Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis. J. Pathol. 216, 55–63 (2008)PubMedCrossRef
6.
go back to reference E. Maquoi, G. Voros, P. Carmeliet, D. Collen, H.R. Lijnen, Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 25, 1002–1007 (2005)PubMedCrossRef E. Maquoi, G. Voros, P. Carmeliet, D. Collen, H.R. Lijnen, Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 25, 1002–1007 (2005)PubMedCrossRef
7.
go back to reference M. Tjwa, L. Bellido-Martin, Y. Lin, E. Lutgens, S. Plaisance, F. Bono, N. Delesque-Touchard, C. Herve, R. Moura, A.D. Billiau, C. Aparicio, M. Levi, M. Daemen, M. Dewerchin, F. Lupu, J. Arnout, J.M. Herbert, M. Waer, P. Garcia de Frutos, B. Dahlback, P. Carmeliet, M.F. Hoylaerts, L. Moons, Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111, 4096–4105 (2008)PubMedCrossRef M. Tjwa, L. Bellido-Martin, Y. Lin, E. Lutgens, S. Plaisance, F. Bono, N. Delesque-Touchard, C. Herve, R. Moura, A.D. Billiau, C. Aparicio, M. Levi, M. Daemen, M. Dewerchin, F. Lupu, J. Arnout, J.M. Herbert, M. Waer, P. Garcia de Frutos, B. Dahlback, P. Carmeliet, M.F. Hoylaerts, L. Moons, Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 111, 4096–4105 (2008)PubMedCrossRef
8.
go back to reference P.J. Godowski, M.R. Mark, J. Chen, M.D. Sadick, H. Raab, R.G. Hammonds, Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 82, 355–358 (1995)PubMedCrossRef P.J. Godowski, M.R. Mark, J. Chen, M.D. Sadick, H. Raab, R.G. Hammonds, Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 82, 355–358 (1995)PubMedCrossRef
9.
go back to reference S. Goruppi, E. Ruaro, C. Schneider, Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12, 471–480 (1996)PubMed S. Goruppi, E. Ruaro, C. Schneider, Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12, 471–480 (1996)PubMed
10.
go back to reference E.C. Shugart, A.S. Levenson, C.M. Constance, R.M. Umek, Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte development. Cell Growth Differ. 6, 1541–1547 (1995)PubMed E.C. Shugart, A.S. Levenson, C.M. Constance, R.M. Umek, Differential expression of gas and gadd genes at distinct growth arrest points during adipocyte development. Cell Growth Differ. 6, 1541–1547 (1995)PubMed
11.
go back to reference C. Ekman, A. Gottsater, B. Lindblad, B. Dahlback, Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin. Biochem. 43, 873–876 (2010)PubMedCrossRef C. Ekman, A. Gottsater, B. Lindblad, B. Dahlback, Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin. Biochem. 43, 873–876 (2010)PubMedCrossRef
12.
go back to reference C. Ekman, A. Linder, P. Akesson, B. Dahlback, Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit. Care (London, England) 14, R158 (2010)CrossRef C. Ekman, A. Linder, P. Akesson, B. Dahlback, Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit. Care (London, England) 14, R158 (2010)CrossRef
13.
go back to reference S. Gibot, F. Massin, A. Cravoisy, R. Dupays, D. Barraud, L. Nace, P.E. Bollaert, Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit. Care (London, England) 11, R8 (2007)CrossRef S. Gibot, F. Massin, A. Cravoisy, R. Dupays, D. Barraud, L. Nace, P.E. Bollaert, Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit. Care (London, England) 11, R8 (2007)CrossRef
14.
go back to reference L. Jiang, C.Y. Liu, Q.F. Yang, P. Wang, W. Zhang, Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am. J. Clin. Pathol. 131, 738–743 (2009)PubMedCrossRef L. Jiang, C.Y. Liu, Q.F. Yang, P. Wang, W. Zhang, Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am. J. Clin. Pathol. 131, 738–743 (2009)PubMedCrossRef
15.
go back to reference C. Ekman, A. Jonsen, G. Sturfelt, A.A. Bengtsson, B. Dahlback, Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology 50, 1064–1069 (2011)PubMedCentralPubMedCrossRef C. Ekman, A. Jonsen, G. Sturfelt, A.A. Bengtsson, B. Dahlback, Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology 50, 1064–1069 (2011)PubMedCentralPubMedCrossRef
16.
go back to reference P. Recarte-Pelz, D. Tassies, G. Espinosa, B. Hurtado, N. Sala, R. Cervera, J.C. Reverter, P.G. de Frutos, Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res. Ther. 15, R41 (2013)PubMedCentralPubMedCrossRef P. Recarte-Pelz, D. Tassies, G. Espinosa, B. Hurtado, N. Sala, R. Cervera, J.C. Reverter, P.G. de Frutos, Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res. Ther. 15, R41 (2013)PubMedCentralPubMedCrossRef
17.
go back to reference C.H. Suh, B. Hilliard, S. Li, J.T. Merrill, P.L. Cohen, TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 12, R146 (2010)PubMedCentralPubMedCrossRef C.H. Suh, B. Hilliard, S. Li, J.T. Merrill, P.L. Cohen, TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 12, R146 (2010)PubMedCentralPubMedCrossRef
18.
go back to reference T.A. Gheita, I.H. Bassyouni, R.H. Bassyouni, Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J. Clin. Immunol. 32, 1279–1286 (2012)PubMedCrossRef T.A. Gheita, I.H. Bassyouni, R.H. Bassyouni, Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J. Clin. Immunol. 32, 1279–1286 (2012)PubMedCrossRef
19.
go back to reference H.A. Kim, J.Y. Nam, J.Y. Jeon, J.M. An, J.Y. Jung, C.B. Bae, C.H. Suh, Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. J. Clin. Immunol. 33, 143–150 (2013)PubMedCrossRef H.A. Kim, J.Y. Nam, J.Y. Jeon, J.M. An, J.Y. Jung, C.B. Bae, C.H. Suh, Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. J. Clin. Immunol. 33, 143–150 (2013)PubMedCrossRef
20.
go back to reference Y.J. Hung, C.H. Lee, N.F. Chu, Y.S. Shieh, Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 33, 1840–1844 (2010)PubMedCentralPubMedCrossRef Y.J. Hung, C.H. Lee, N.F. Chu, Y.S. Shieh, Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 33, 1840–1844 (2010)PubMedCentralPubMedCrossRef
21.
go back to reference F.C. Hsiao, Y.F. Lin, P.S. Hsieh, N.F. Chu, Y.S. Shieh, C.H. Hsieh, C.H. Lee, Y.J. Hung, Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents. J. Clin. Endocrinol. Metab. 98, E267–E274 (2013)PubMedCrossRef F.C. Hsiao, Y.F. Lin, P.S. Hsieh, N.F. Chu, Y.S. Shieh, C.H. Hsieh, C.H. Lee, Y.J. Hung, Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents. J. Clin. Endocrinol. Metab. 98, E267–E274 (2013)PubMedCrossRef
22.
go back to reference B.K. Son, M. Akishita, K. Iijima, S. Ogawa, K. Maemura, J. Yu, K. Takeyama, S. Kato, M. Eto, Y. Ouchi, Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J. Biol. Chem. 285, 7537–7544 (2010)PubMedCentralPubMedCrossRef B.K. Son, M. Akishita, K. Iijima, S. Ogawa, K. Maemura, J. Yu, K. Takeyama, S. Kato, M. Eto, Y. Ouchi, Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J. Biol. Chem. 285, 7537–7544 (2010)PubMedCentralPubMedCrossRef
23.
go back to reference S. Clauser, S. Peyrard, P. Gaussem, M. Crespin, J. Emmerich, M. Aiach, D. Borgel, Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin. Chem. 53, 1808–1813 (2007)PubMedCrossRef S. Clauser, S. Peyrard, P. Gaussem, M. Crespin, J. Emmerich, M. Aiach, D. Borgel, Development of a novel immunoassay for the assessment of plasma Gas6 concentrations and their variation with hormonal status. Clin. Chem. 53, 1808–1813 (2007)PubMedCrossRef
24.
go back to reference M. Agirbasli, N.B. Agaoglu, N. Orak, H. Caglioz, T. Ocek, N. Poci, A. Salaj, S. Maya, Sex hormones and metabolic syndrome in children and adolescents. Metabolism 58, 1256–1262 (2009)PubMedCrossRef M. Agirbasli, N.B. Agaoglu, N. Orak, H. Caglioz, T. Ocek, N. Poci, A. Salaj, S. Maya, Sex hormones and metabolic syndrome in children and adolescents. Metabolism 58, 1256–1262 (2009)PubMedCrossRef
25.
go back to reference K. Nagai, H. Arai, M. Yanagita, T. Matsubara, H. Kanamori, T. Nakano, N. Iehara, A. Fukatsu, T. Kita, T. Doi, Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278, 18229–18234 (2003)PubMedCrossRef K. Nagai, H. Arai, M. Yanagita, T. Matsubara, H. Kanamori, T. Nakano, N. Iehara, A. Fukatsu, T. Kita, T. Doi, Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278, 18229–18234 (2003)PubMedCrossRef
26.
go back to reference R. Mo, Y. Tony Zhu, Z. Zhang, S.M. Rao, Y.J. Zhu, GAS6 is an estrogen-inducible gene in mammary epithelial cells. Biochem. Biophys. Res. Commun. 353, 189–194 (2007)PubMedCentralPubMedCrossRef R. Mo, Y. Tony Zhu, Z. Zhang, S.M. Rao, Y.J. Zhu, GAS6 is an estrogen-inducible gene in mammary epithelial cells. Biochem. Biophys. Res. Commun. 353, 189–194 (2007)PubMedCentralPubMedCrossRef
27.
go back to reference Y. Miki, T. Suzuki, S. Nagasaki, S. Hata, J. Akahira, H. Sasano, Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J. Steroid Biochem. Mol. Biol. 113, 281–289 (2009)PubMedCrossRef Y. Miki, T. Suzuki, S. Nagasaki, S. Hata, J. Akahira, H. Sasano, Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J. Steroid Biochem. Mol. Biol. 113, 281–289 (2009)PubMedCrossRef
28.
go back to reference B.K. Son, K. Kozaki, K. Iijima, M. Eto, T. Nakano, M. Akishita, Y. Ouchi, Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur. J. Pharmacol. 556, 1–8 (2007)PubMedCrossRef B.K. Son, K. Kozaki, K. Iijima, M. Eto, T. Nakano, M. Akishita, Y. Ouchi, Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur. J. Pharmacol. 556, 1–8 (2007)PubMedCrossRef
Metadata
Title
Plasma growth arrest-specific protein 6 levels in premenopausal and postmenopausal women: the role of endogenous estrogen
Authors
Yi-Jen Hung
Chien-Hsing Lee
Yi-Shing Shieh
Fone-Ching Hsiao
Fu-Huang Lin
Chang-Hsun Hsieh
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0234-x

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.